CIBC Private Wealth Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $163K | Sell |
961
-1,107
| -54% | -$170K | ﹤0.01% | 1289 |
|
|
2025
Q3 | $273K | Buy |
2,068
+5
| +0.2% | +$600 | ﹤0.01% | 1048 |
|
|
2025
Q2 | $219K | Buy |
2,063
+1,871
| +974% | +$203K | ﹤0.01% | 1091 |
|
|
2025
Q1 | $19.7K | Buy |
192
+42
| +28% | +$5.48K | ﹤0.01% | 1997 |
|
|
2024
Q4 | $18K | Sell |
150
-174
| -54% | -$20.5K | ﹤0.01% | 2100 |
|
|
2024
Q3 | $36.1K | Buy |
324
+126
| +64% | +$13.8K | ﹤0.01% | 1896 |
|
|
2024
Q2 | $19.9K | Buy |
198
+4
| +2% | +$440 | ﹤0.01% | 2031 |
|
|
2024
Q1 | $23.1K | Buy |
+194
| New | +$23.8K | ﹤0.01% | 1993 |
|
|
2023
Q4 | – | Sell |
-1,719
| Closed | -$223K | – | 1163 |
|
|
2023
Q3 | $223K | Buy |
+1,719
| New | +$229K | ﹤0.01% | 974 |
|
|
2023
Q2 | – | Sell |
-22,157
| Closed | -$506K | – | 897 |
|
|
2023
Q1 | $506K | Sell |
22,157
-38,317
| -63% | -$5.67M | ﹤0.01% | 705 |
|
|
2022
Q4 | $9.63M | Sell |
60,474
-1,263
| -2% | -$185K | 0.03% | 274 |
|
|
2022
Q3 | $8.23M | Sell |
61,737
-920
| -1% | -$140K | 0.02% | 319 |
|
|
2022
Q2 | $9.78M | Sell |
62,657
-72,418
| -54% | -$11.1M | 0.03% | 307 |
|
|
2022
Q1 | $21M | Buy |
135,075
+16,655
| +14% | +$2.42M | 0.05% | 242 |
|
|
2021
Q4 | $15.1M | Sell |
118,420
-1,196
| -1% | -$157K | 0.03% | 292 |
|
|
2021
Q3 | $15.6M | Sell |
119,616
-45,653
| -28% | -$6.9M | 0.04% | 292 |
|
|
2021
Q2 | $29.4M | Sell |
165,269
-207
| -0.1% | -$35.9K | 0.07% | 202 |
|
|
2021
Q1 | $27.2M | Buy |
165,476
+51,485
| +45% | +$8.47M | 0.07% | 206 |
|
|
2020
Q4 | $18.8M | Sell |
113,991
-3,673
| -3% | -$547K | 0.05% | 248 |
|
|
2020
Q3 | $16.8M | Sell |
117,664
-4,074
| -3% | -$505K | 0.05% | 231 |
|
|
2020
Q2 | $13.4M | Buy |
121,738
+33,821
| +38% | +$3.74M | 0.07% | 198 |
|
|
2020
Q1 | $8.77M | Sell |
87,917
-1,769
| -2% | -$229K | 0.04% | 264 |
|
|
2019
Q4 | $13.4M | Sell |
89,686
-43,485
| -33% | -$5.92M | 0.04% | 253 |
|
|
2019
Q3 | $17.1M | Sell |
133,171
-2,533
| -2% | -$340K | 0.06% | 221 |
|
|
2019
Q2 | $19.3M | Buy |
135,704
+4,693
| +4% | +$631K | 0.07% | 209 |
|
|
2019
Q1 | $18.7M | Buy |
131,011
+5,134
| +4% | +$670K | 0.07% | 207 |
|
|
2018
Q4 | $15.6M | Buy |
125,877
+2,343
| +2% | +$348K | 0.07% | 214 |
|
|
2018
Q3 | $20.8M | Buy |
123,534
+3,039
| +3% | +$523K | 0.08% | 208 |
|
|
2018
Q2 | $20.8M | Buy |
120,495
+9,651
| +9% | +$1.58M | 0.08% | 203 |
|
|
2018
Q1 | $16.7M | Buy |
110,844
+37,192
| +50% | +$5.46M | 0.07% | 224 |
|
|
2017
Q4 | $9.92M | Buy |
73,652
+10,157
| +16% | +$1.41M | 0.04% | 289 |
|
|
2017
Q3 | $9.29M | Buy |
63,495
+1,680
| +3% | +$254K | 0.04% | 287 |
|
|
2017
Q2 | $9.61M | Buy |
+61,815
| New | +$9.45M | 0.06% | 222 |
|
|
2016
Q4 | – | Sell |
-42,787
| Closed | -$5.2M | – | 587 |
|
|
2016
Q3 | $5.2M | Buy |
42,787
+811
| +2% | +$109K | 0.04% | 278 |
|
|
2016
Q2 | $5.93M | Buy |
41,976
+384
| +0.9% | +$56.6K | 0.04% | 252 |
|
|
2016
Q1 | $5.43M | Buy |
41,592
+1,404
| +3% | +$175K | 0.04% | 257 |
|
|
2015
Q4 | $5.65M | Sell |
40,188
-545
| -1% | -$75.5K | 0.04% | 254 |
|
|
2015
Q3 | $5.41M | Buy |
40,733
+523
| +1% | +$90.1K | 0.04% | 262 |
|
|
2015
Q2 | $7.08M | Sell |
40,210
-51
| -0.1% | -$9.16K | 0.05% | 251 |
|
|
2015
Q1 | $6.96M | Buy |
40,261
+2,584
| +7% | +$443K | 0.05% | 247 |
|
|
2014
Q4 | $6.17M | Buy |
37,677
+44
| +0.1% | +$7.3K | 0.05% | 255 |
|
|
2014
Q3 | $6.04M | Buy |
37,633
+11,723
| +45% | +$1.8M | 0.05% | 261 |
|
|
2014
Q2 | $3.81M | Buy |
+25,910
| New | +$3.59M | 0.03% | 298 |
|
Other funds holding JAZZ
EC
CIBC Private Wealth Group's JAZZ Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 54% in Q4 2025, selling an estimated $170K and leaving 961 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.
CIBC Private Wealth Group first reported a position in JAZZ in Q2 2014 and has held it in 43 quarters since. The position peaked at $29.4M in Q2 2021. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.
- CIBC Private Wealth Group held 961 shares of Jazz Pharmaceuticals worth $163K as of Q4 2025.
- CIBC Private Wealth Group sold 1,107 Jazz Pharmaceuticals shares in Q4 2025, an estimated $170K.
- Jazz Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1289 holding.
- CIBC Private Wealth Group first reported a position in Jazz Pharmaceuticals in Q2 2014 and has held it in 43 quarters since.
- CIBC Private Wealth Group's Jazz Pharmaceuticals position peaked at $29.4M in Q2 2021.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.